BioForce Nanosciences Holdings, Inc. (BFNH)
| Market Cap | 357.17M +1,213.8% |
| Revenue (ttm) | n/a |
| Net Income | -97.44K |
| EPS | -0.00 |
| Shares Out | 38.07M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,336 |
| Open | 8.62 |
| Previous Close | 9.32 |
| Day's Range | 8.62 - 9.84 |
| 52-Week Range | 0.18 - 10.99 |
| Beta | -0.29 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 11, 2026 |
About BFNH
BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. It offers private label products with distributors and manufacturing providers. The company also sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www.bioforceeclipse.com, as well as through social media and telemarketing channels. BioForce Nanosciences Holdings, Inc. is based in Virginia Beach, Virg... [Read more]
Financial Performance
Financial StatementsNews
Bioforce Nanosciences Holdings, Inc. Announces Strategic Oil and Gas Leases in Nevada
VIRGINIA BEACH, Va., July 15, 2026 (GLOBE NEWSWIRE) -- Bioforce Nanosciences Holdings, Inc. (OTC: BFNH) (“Bioforce” or the “Company”) announces that the U.S. Bureau of Land Management (BLM) has approv...